STOCK TITAN
  1. Home
  2. SEC Filings
  3. FMAO
  4. [144] FARMERS & MERCHANTS BANCORP INC SEC Filing

Farmers & Merchants Bancorp files Rule 144 notice for 12,000 shares

Farmers & Merchants Bancorp, Inc. submitted a notice under Rule 144 reporting intended and recent dispositions of Common Stock.

Filing Impact
(Neutral)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
144

Rhea-AI Filing Summary

Farmers & Merchants Bancorp, Inc. submitted a notice under Rule 144 reporting intended and recent dispositions of Common Stock. The cover lists 12,000 shares with an aggregate value of $345,600 and a reference outstanding figure of 13,768,188 shares as of 06/15/2026. The filing also itemizes multiple 3,000-share open-market sales by Andrew Briggs on dates between 05/12/2026 and 06/12/2026, each showing the gross proceeds for that trade.

Insights

Routine Rule 144 disposition notices list specific sale dates and per-trade proceeds; this filing is informational.

The filing presents a declared block of 12,000 shares for sale and a sequence of executed open-market sales by Andrew Briggs in 3,000-share increments on multiple dates from 05/12/2026 through 06/12/2026. Each row shows the trade date and the transaction value.

These entries are procedural disclosures under Rule 144; cash-flow treatment and whether the listed 12,000 shares are the same instruments sold in the listed trades are not explicitly reconciled in the excerpt. Subsequent filings would show any further disposals or confirmations.

Registered/To be sold 12,000 shares listed on cover line associated with offering
Aggregate value (cover line) $345,600.00 associated with the 12,000-share line
Shares outstanding 13,768,188 shares as of 06/15/2026 (listed on the cover line)
Per-trade quantity 3,000 shares each listed sale by Andrew Briggs between 05/12/2026 and 06/12/2026
Example trade proceeds $81,600.00 proceeds for the 3,000-share sale on 05/12/2026
Example trade proceeds $85,170.00 proceeds for the 3,000-share sale on 06/12/2026
Rule 144 regulatory
"Securities To Be Sold / Securities Sold During The Past 3 Months"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Open Market market
"Common Stock | 03/25/1999 | Purchase | Open Market"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
Aggregate value financial
"12000 | 345600.00 | 13768188 | 06/15/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Rule 144 notice for FMAO show?
It reports a declared offering of 12,000 shares with an aggregate value of $345,600 and lists multiple past sales by an affiliated holder between 05/12/2026 and 06/12/2026.

Who executed the recent open-market sales listed in the filing for FMAO?
The filing lists multiple open-market sales executed by Andrew Briggs (c/o Farmers & Merchants Bancorp) in 3,000-share increments on specific dates from 05/12/2026 to 06/12/2026, with each trade's proceeds shown.

Does the filing state total shares outstanding for FMAO?
Yes; the excerpt includes a reference to 13,768,188 shares outstanding as of 06/15/2026, presented alongside the offering line items in the notice.

Are the per-trade proceeds disclosed in the Rule 144 notice?
Yes; each listed sale by Andrew Briggs shows a per-trade gross amount (for example, $81,600.00 on 05/12/2026 and $85,170.00 on 06/12/2026), paired with the 3,000-share quantity.

Does this Rule 144 filing indicate who receives the cash proceeds?
The excerpt does not attach a purchaser or beneficiary statement to the proceeds; the entries list the seller and per-trade gross amounts but do not explicitly state the recipient of sale proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Accepted by SEC EDGAR

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

Keep reading

More on FMAO

All FMAO news

Trending in the feed

LQDA
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH Open the live feed